The Pro’s and Con’s of Medical Device Materials

September 14, 2020 / by Kapstone Medical / 5 minute read

 

Medical Device Material Selection: Pros and Cons Medical Device Companies Need to Know

Material selection is one of the most challenging—and important—components of medical device development. No matter how strong a concept or dedicated a team, selecting the wrong material can jeopardize a device’s commercialization timeline and likelihood of regulatory approval. Fortunately, the Kapstone team of experts is well-versed in device material selection and manufacturing as well as the testing needed to go with it. Our mission is to inspire, equip, and guide our partners in bringing the highest quality medical devices to market, which includes the material safety and effectiveness. 

Read More

5 Ways Medical Device Development Companies Can Save Money When Developing Products

August 12, 2020 / by Kapstone Medical / 5 minute read

A Conversation With John Kapitan | Founder & CEO, Kapstone Medical

Medical device development companies large and small face different hurdles when bringing a new device to market. However, no matter their size, all companies cope with the inherent unpredictability of the development process—which, due to shifting regulatory guidance, the complexity of device manufacturing, and other factors, can quickly overwhelm timelines and budgets. 

Read More

Using Competitor Research Throughout the Medical Device Product Development Lifecycle

May 26, 2020 / by Kapstone Medical / 6 minute read

A Conversation With David Walsh | Director of Engineering

 

According to David Walsh, Director of Engineering at Kapstone, medical device companies really only have one goal: to “make sure their device is ultimately widely accepted in the market, easily understood, and can be used safely and effectively.” Sums it up, doesn’t it?

Read More

Solving The Top 4 Challenges Medical Device Companies Face When Developing New Products

May 15, 2020 / by Kapstone Medical / 5 minute read

A Conversation With Justin Rowland | Project Manager

Bringing a medical device to market is difficult for startup and established medical device companies alike. Though the development and approval process can sometimes take years, those years are jam-packed with requirements and milestones that can challenge even the most experienced companies.

Read More

510(k) Premarket Notifications: How to Determine Substantial Equivalence

April 15, 2020 / by Kapstone Medical / 5 minute read

A Conversation with Kellen Hills | Regulatory Affairs Specialist, Kapstone Medical

Since 1906, the US Food and Drug Administration (more commonly known as the FDA) has protected consumers against the threat posed by adulterated, mislabeled, unsafe, or otherwise ineffective food and drug products. Regulatory affairs consultant Kellen Hills notes that before the FDA was empowered to regulate these products, “people were getting sick and dying because of unsavory characters putting things out on the market, making false claims about what they did with no oversight.” 

Read More

How Outsourced Regulatory Affairs Consultation Can Save Your Medical Device Company Time and Money

March 31, 2020 / by Justin Rowland / 4 minute read

A Conversation with John Kapitan | Founder & CEO, Kapstone Medical

Bringing a medical device to market is a challenging process, to say the least. From ideation to product classification to obtaining final approval in a target market, so many of these necessary steps can become pain points for established and fledgling companies alike. 

Read More

European MDR: EUDAMED Database and UDI

January 16, 2020 / by Kapstone Medical / 3 minute read

Part 7 in a 7-part series on the EU’s Medical Device Regulation

The European Database for Medical Devices (EUDAMED) was conceived 20 years ago in 1998, originally as part of the In Vitro Diagnostics Devices Directive (IVDD) and included the Medical Devices Directive (MDD).

Under the new MDR that replaces the MDD, the European Commission recognized that to fully support the more stringent requirements for filing, reporting, and continuing surveillance, it would need to greatly expand the capabilities of the database for monitoring and data collection.

Read More

European MDR: Post-Market Surveillance

January 8, 2020 / by Kapstone Medical / 3 minute read

Part 6 in a 7-part series on the EU’s Medical Device Regulation

The new EU Medical Device Regulation (MDR) builds on the framework of the MDD with an increased emphasis on post-market surveillance (PMS) and post-market clinical follow-up (PMCF) that moves closer to the FDA’s approach.

The FDA defines PMS as the process of “active, systematic, scientifically valid collection, analysis and interpretation of data and other information about a marketed device.”

Read More

EU MDR: How Clinical Evidence Requirements Affect Medical Device Approvals

December 18, 2019 / by Kapstone Medical / 3 minute read

Part 5 in a 7-part series on the EU’s Medical Device Regulation

Among the significant changes facing device makers transitioning their products in the European Union from the Medical Device Directives (MDD) to the Medical Device Regulation (MDR) are the new requirements around clinical evidence.

Under the MDR, device manufacturers marketing products in the EU will face some additional hurdles, but if you also market in the US, Canada, Japan, or other countries, the new regulations will likely be familiar to you.

Read More

European MDR: Product Portfolios and Technical Documentation

December 12, 2019 / by Kapstone Medical / 4 minute read

Part 4 in our 7-part series on meeting the new requirements under the EU MDR

Complying with the European Union’s Medical Device Regulation (MDR) poses a daunting task for medical device makers marketing products inside the EU. One of the most taxing efforts for companies that already have CE-marked devices in the EU is the need for portfolio reviews.

Read More

Subscribe for the Latest News

Categories:

See all